Prentice Capital Management’s Nu Skin NUS Stock Holding History

Prentice Capital Management’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-262,421	Closed	-$5.73M	–	29
2020 Q1	$5.73M	Buy	+262,421	New	+$7.9M	2.72%	11

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Prentice Capital Management's NUS Position: Q2 2020 in Review

Prentice Capital Management sold out of Nu Skin (NUS) in Q2 2020, closing a stake of 262,421 shares — an estimated $5.73M sold.

Prentice Capital Management first reported a position in NUS in Q1 2020 and held it in 1 quarter. The position peaked at $5.73M in Q1 2020. 226 funds tracked by Wall St. Rank hold NUS as of Q2 2020.

Prentice Capital Management reported no remaining Nu Skin position as of Q2 2020 after selling out during the quarter.
Prentice Capital Management sold 262,421 Nu Skin shares in Q2 2020, an estimated $5.73M.
Prentice Capital Management first reported a position in Nu Skin in Q1 2020 and held it in 1 quarter.
Prentice Capital Management's Nu Skin position peaked at $5.73M in Q1 2020.
226 funds tracked by Wall St. Rank held Nu Skin as of Q2 2020.

Based on Prentice Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.